Hypersensitivity to the components of the drug, skin diseases, violation of the integrity of the skin, inflammatory skin diseases in: the bridge of the alleged application of the drug (including dermatitis, eczema).
Pregnancy, the period of breastfeeding, children under 18 (due to the lack of data on the safety of the drug in this category of patients).